Specifically, a more thorough examination of the biological roles and mechanisms governing the differential regulation of HPGD, PACS1, and TDP2 in CRC is necessary, as this could elucidate the pathways through which these genes contribute to tumor biology, particularly in light of the conflicting TDP2 results. The gene discussed is PACS1; the disease is neoplasm.